Indeed, enhancing the PI3K/Akt/mTORC1 signaling pathway improved deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an AD mouse model [89]. This evidence concerns the gene AKT1 and Alzheimer disease.